Quick Answer
Oncology Institute, Inc. reported Long Term Debt of $77.40 million for the year ending 2025.
- Oncology Institute, Inc. showed a decrease of -16.9% in Long Term Debt from 2024 to 2025.
- This data is from Oncology Institute, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $79.07 million | Q1 2023: $82.14 million | Q2 2023: $83.69 million | Q3 2023: $85.25 million | Q1 2024: $88.39 million | Q2 2024: $89.95 million | Q3 2024: $91.54 million | Q1 2025: $73.89 million | Q2 2025: $75.02 million | Q3 2025: $76.20 million.
- Over the full 6 years of available data (2020 to 2025), Oncology Institute, Inc.'s Long Term Debt has grown by 1,079.7%.
- Historical annual values: Fiscal year 2025: $77.40 million | Fiscal year 2024: $93.13 million | Fiscal year 2023: $86.83 million | Fiscal year 2022: $80.62 million | Fiscal year 2021: $0.00 | Fiscal year 2020: $6.56 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: